Literature DB >> 33357632

Glutamate and Gamma-Aminobutyric Acid Abnormalities in Antipsychotic-Naïve Patients With Schizophrenia: Evidence From Empirical and Meta-analytic Studies Using Magnetic Resonance Spectroscopy.

Meredith A Reid1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33357632      PMCID： PMC8221118          DOI： 10.1016/j.biopsych.2020.11.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

1.  Mapping of brain macromolecules and their use for spectral processing of (1)H-MRSI data with an ultra-short acquisition delay at 7 T.

Authors:  Michal Považan; Gilbert Hangel; Bernhard Strasser; Stephan Gruber; Marek Chmelik; Siegfried Trattnig; Wolfgang Bogner
Journal:  Neuroimage       Date:  2015-07-22       Impact factor: 6.556

2.  A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.

Authors:  Meredith A Reid; David M White; Nina V Kraguljac; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2015-12-21       Impact factor: 4.939

3.  Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

Authors:  Juan R Bustillo; Hongji Chen; Charles Gasparovic; Paul Mullins; Arvind Caprihan; Clifford Qualls; William Apfeldorf; John Lauriello; Stefan Posse
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

4.  Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.

Authors:  Camilo de la Fuente-Sandoval; Francisco Reyes-Madrigal; Xiangling Mao; Pablo León-Ortiz; Oscar Rodríguez-Mayoral; Helgi Jung-Cook; Rodolfo Solís-Vivanco; Ariel Graff-Guerrero; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2017-10-10       Impact factor: 13.382

5.  Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.

Authors:  Luke A Jelen; Sinead King; Charlotte M Horne; David J Lythgoe; Allan H Young; James M Stone
Journal:  Eur Neuropsychopharmacol       Date:  2018-12-14       Impact factor: 4.600

6.  Glutamate in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: A Meta-analysis of 1H-Magnetic Resonance Spectroscopy Studies.

Authors:  Jakob Kaminski; Lea Mascarell-Maricic; Yu Fukuda; Teresa Katthagen; Andreas Heinz; Florian Schlagenhauf
Journal:  Biol Psychiatry       Date:  2020-09-08       Impact factor: 13.382

7.  Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

Authors:  Shin'Ya Tayoshi; Satsuki Sumitani; Kyoko Taniguchi; Sumiko Shibuya-Tayoshi; Shusuke Numata; Jun-ichi Iga; Masahito Nakataki; Shu-ichi Ueno; Masafumi Harada; Tetsuro Ohmori
Journal:  Schizophr Res       Date:  2008-12-20       Impact factor: 4.939

8.  Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.

Authors:  Kirsten Borup Bojesen; Brian Villumsen Broberg; Birgitte Fagerlund; Kasper Jessen; Marie Bjerregaard Thomas; Anne Sigvard; Karen Tangmose; Mette Ødegaard Nielsen; Gitte Saltoft Andersen; Henrik Bo Wiberg Larsson; Richard A E Edden; Egill Rostrup; Birte Yding Glenthøj
Journal:  Biol Psychiatry       Date:  2020-07-10       Impact factor: 13.382

9.  Macromolecule-suppressed GABA measurements correlate more strongly with behavior than macromolecule-contaminated GABA+ measurements.

Authors:  Mark Mikkelsen; Ashley D Harris; Richard A E Edden; Nicolaas A J Puts
Journal:  Brain Res       Date:  2018-09-19       Impact factor: 3.252

10.  Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.

Authors:  Kirsten B Bojesen; Bjørn H Ebdrup; Kasper Jessen; Anne Sigvard; Karen Tangmose; Richard A E Edden; Henrik B W Larsson; Egill Rostrup; Brian V Broberg; Birte Y Glenthøj
Journal:  Psychol Med       Date:  2019-09-16       Impact factor: 7.723
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.